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Replacement of GroEL in Escherichia coli by the Group II Chaperonin
from the Archaeon Methanococcus maripaludis
Riddhi Shah,a Andrew T. Large,a Astrid Ursinus,b Bevan Lin,a Preethy Gowrinathan,a Jörg Martin,b Peter A. Lunda
School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdoma; Max Planck Institute for Developmental Biology, Tübingen, Germanyb
ABSTRACT
Chaperonins are required for correct folding of many proteins. They exist in two phylogenetic groups: group I, found in bacteria
and eukaryotic organelles, and group II, found in archaea and eukaryotic cytoplasm. The two groups, while homologous, differ
significantly in structure andmechanism. The evolution of group II chaperonins has been proposed to have been crucial in en-
abling the expansion of the proteome required for eukaryotic evolution. In an archaeal species that expresses both groups of
chaperonins, client selection is determined by structural and biochemical properties rather than phylogenetic origin. It is thus
predicted that group II chaperonins will be poor at replacing group I chaperonins. We have tested this hypothesis and report
here that the group II chaperonin fromMethanococcus maripaludis (Mm-cpn) can partially functionally replace GroEL, the
group I chaperonin of Escherichia coli. Furthermore, we identify and characterize two single point mutations in Mm-cpn that
have an enhanced ability to replace GroEL function, including one that allows E. coli growth after deletion of the groEL gene. The
biochemical properties of the wild-type andmutant Mm-cpn proteins are reported. These data show that the two groups are not
as functionally diverse as has been thought and provide a novel platform for genetic dissection of group II chaperonins.
IMPORTANCE
The two phylogenetic groups of the essential and ubiquitous chaperonins diverged approximately 3.7 billion years ago. They
have similar structures, with two rings of multiple subunits, and their major role is to assist protein folding. However, they differ
with regard to the details of their structure, their cofactor requirements, and their reaction cycles. Despite this, we show here
that a group II chaperonin from amethanogenic archaeon can partially substitute for the essential group I chaperonin GroEL in
E. coli and that we can easily isolate mutant forms of this chaperonin with further improved functionality. This is the first dem-
onstration that these two groups, despite the long time since they diverged, still overlap significantly in their functional
properties.
Molecular chaperones are a group of diverse proteins, inten-sively studied over the last 3 decades, whose overall role is to
maintain all components of the cellular proteome at their opti-
mum level for activity by ensuring that they are fully folded (1–3).
Chaperonins are a nearly ubiquitous subset of molecular chaper-
ones, closely related by homology and active as double-ringed,
cagelike oligomeric protein complexes made of 60-kDa mono-
mers (4–6). They are found in all organisms except for a few my-
coplasmas (7) and have been shown to be essential in bacteria,
archaea, and eukaryotes (8–10). They are ATP-driven molecular
machines that work by encapsulating unfolded or misfolded pro-
teins that can then fold effectively in the secluded central cavity.
Chaperonins are divided into two groups based on phylogeny:
group I chaperonins (found principally in bacteria and eukaryotic
organelles) and group II chaperonins (found in eukaryotic cyto-
plasm and in archaea, where they are generally referred to as ther-
mosomes). The subunits of chaperonins from both groups share
similar domain architecture and comprise three distinct domains:
a flexible apical domain that harbors a client binding site, an equa-
torial domain that mediates ATP binding and hydrolysis, and an
intermediate domain that relays allosteric signals between the api-
cal and intermediate domain via two hinge regions. The subunits
assemble into a large complex consisting of two rings of seven
(group I) or eight or nine (group II) subunits, with the central
cavities in the two rings being the likely site of protein folding
during the ATP-driven protein-folding cycle (4–6, 11, 12).
Despite their homology, significant differences separate the
two groups. For example, although many bacteria contain more
than one chaperonin (13), in most cases studied they are homo-
oligomeric, whereas group II chaperonins, with the exception of
few archaeal chaperonins, are hetero-oligomeric. Second, the ac-
tivity of a cochaperonin that caps the protein-folding cavity is a
requirement for group I chaperonin function but does not apply
to group II chaperonins, due to the presence of an additional
helical protrusion from the protein’s apical domain that provides
this function (14, 15). Third, in group I chaperonins the subunits
are staggered between the two rings, whereas in group II they are
in register, and this appears to result in significant differences in
their allosteric behavior (12, 15–18). Fourth, the surface charge
distributions of the inner closed cavity show significant differ-
ences between the two groups (19). These differences have been
attributed to the coevolution of chaperonins with their clients in
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respective host organisms. For example, the transition from ho-
mo-oligomeric chaperonin rings in group I to a mostly hetero-
oligomeric distribution in group II has been suggested to have
occurred in parallel with the evolution of complex proteins in
higher organisms (20, 21), and the number of different subunits in
organisms that encode group II chaperonins correlates strikingly
with proteome size (22). Group II chaperonins have been re-
ported to interact with faster-evolving proteins that have greater
structural variety, in contrast to comparatively more conserved,
slower-evolving clients for group I chaperonins (21, 23). ATPase
allostery is altered from a concerted one in group I chaperonins to
a sequential one in group II, and this has been suggested to medi-
ate the ordered release of multidomain proteins bound specifically
to selected subunits in group II chaperonins, in contrast to simul-
taneous release from all subunits in group I chaperonins (24, 25).
The various surface properties of the chaperonin cage in group I
and group II chaperonins have also been proposed to be associ-
ated with differential client specificity (19, 26).
GroEL fromEscherichia coli and mitochondrial heat shock pro-
tein 60 (Hsp60) are unable to fold the major eukaryotic TRiC
clients, actin and tubulin, in vitro, and it has also been reported
that bacterial proteins that require GroEL assistance are unable to
fold in the eukaryotic cytosol (27, 28). Moreover, in the archaeon
Methanosarcina mazei, which encodes both group I and group II
chaperonins, nonoverlapping sets of clients that exclusively re-
quire one of the two chaperonins were found, and some of these
are predicted to be essential (23). All these studies imply that client
optimization is a key driver of divergence between group I and
group II chaperonins. However, further experimental evidence is
still needed to support this hypothesis. Moreover, the precise na-
ture of how structural differences between representatives of the
two groups contribute to changes in their respective mechanisms
of action is not fully resolved, one of the limitations being the high
degree of structural complexity in most group II chaperonins and
comparatively difficult in vivo analysis in archaeal and eukaryotic
expression systems.
On the other hand, over 80% of the TRiC interactors have been
shown to be recognized (though not folded) by GroEL (29), in-
cluding the obligate TRiC clients actin and tubulin. This implies a
relatively broad range of client specificity, probably reflecting
common elements for client recognition between group I and
group II chaperonins. The apparent client specificity of group II
chaperonins thus may have more to do with their ability to fold
specific clients rather than their ability to recognize them. More-
over, while the subunit-specific functionalization is complete in
eukaryotic chaperonins, archaeal chaperonins do not show abso-
lute subfunctionalization (30). Thus, group I and group II chap-
eronins may show some functional overlap, and this may be pre-
dicted to be more evident with archaeal thermosomes than with
the more complex eukaryotic chaperonins.
Functional expression of a group II chaperonin in an organism
that normally requires a group I chaperonin would help the un-
derstanding of the extent and basis of functional divergence be-
tween the two groups and would also allow genetic dissection of
the properties of group II chaperonins in a simple host. We have
therefore investigated whether an archaeal chaperonin can replace
GroEL function in E. coli, using the chaperonin from the mesoph-
ilic archaeon Methanococcus maripaludis, which we designate
Mm-cpn. It was chosen for the following reasons: (i) Mm-cpn is
homo-oligomeric, which as well as facilitating recombinant ex-
pression and mutagenesis in bacterial hosts means that it repre-
sents the simplest form of thermosome; (ii) the optimum temper-
ature of growth for the parent organism is 35°C to 40°C, so the
chaperonin is expected to exhibit functionality at roughly the
same temperature optimum as that of E. coli; and (iii) this chap-
eronin has already been expressed in E. coli and characterized for
ATPase and in vitro folding properties, and its structure has been
solved (31–34).
MATERIALS AND METHODS
Strains and plasmids. The strain TAB21 was derived from E. coli
MGM100 (31) and contains the groE operon under the control of the
arabinose- and glucose-regulated pBAD promoter in a BL21 background.
AI90 is a strain in which the chromosomal copy of groELhas been replaced
by a kanamycin resistance cassette. Growth is maintained by ptrc-regu-
lated groEL on an expression plasmid that also carries a sacB gene to enable
selection for cells that have lost this plasmid after introducing plasmids
expressing proteins whose ability to complement is to be assayed (32, 33).
Vectors pET21b() (Novagen) and pACYC184 were used for construct-
ing all the plasmids used for complementation assays in TAB21 and AI90,
respectively.
Plate assay for complementation of GroEL function. TAB21 cells
containing test plasmids were grown overnight at 37°C with 0.2% arabi-
nose and then diluted and grown for 2 h in LB medium containing 0.2%
glucose. Cells equivalent to an optical density at 600 nm (OD600) of 1 were
harvested and washed three times using LB broth. Tenfold dilutions of the
washed cells were spotted onto LB agar plates containing 0.2% arabinose or
0.2% glucose with or without isopropyl--D-thiogalactopyranoside
(IPTG; 1 mM) and incubated at 26°C, 30°C, or 37°C. AI90 cells were
transformed with appropriate plasmids and grown on LB agar plates con-
taining sucrose with or without IPTG. The plates were incubated at 26°C,
30°C, or 37°C and scored for growth.
Random mutagenesis using XL-1 mutator strain. The pET21-Mm-
cpn plasmid was transformed into XL-1 Red strain (Agilent Technolo-
gies), and cells were plated onto LB agar containing ampicillin. All the
colonies obtained were mixed together by resuspending in 500 l LB on
the plate and were cultured overnight at 37°C in 100 ml of LB containing
ampicillin. For a higher mutation rate, these cultures were subcultured
and grown overnight for two cycles. After this, plasmids were isolated,
transformed into TAB21, and grown on plates containing LB agar with
kanamycin, ampicillin, 0.2% glucose, and 1 mM IPTG. Plates were
screened visually for faster-growing colonies.
Purification of mutant Mm-cpn. Purification was carried out essen-
tially as described previously (34, 35) with modifications as described
below. Cultures of E. coli BL21(DE3) (Novagen) cells carrying the pET
plasmid constructs of Mm-cpn mutants were grown from an overnight
culture in LB medium at 37°C until an OD600 of 0.4 was achieved. Protein
expression was induced by addition of 1 mM IPTG, and the cultures were
further grown for 4 h. Cells were harvested by centrifugation, and pellets
were resuspended in lysis buffer (30 mM Tris-HCl [pH 7.5], 50 mM NaCl,
5 mM MgCl2, 15% ethanol [vol/vol], 1 mM phenylmethylsulfonyl fluo-
ride [PMSF], 1 mM protease inhibitor cocktail [Roche]). After lysis of the
cells using a French press, the lysate was centrifuged twice at 25,000  g
and filtered through a 0.2-m filter. The clear supernatant was applied to
a Q high-performance (QHP) anion exchange column preequilibrated
with column buffer A (30 mM Tris-HCl [pH 7.5], 5 mM NaCl, 5 mM
MgCl2, 1 mM dithiothreitol [DTT]). Elution was achieved with a linear
gradient of 0 to 50% of column buffer B (30 mM Tris-HCl [pH 7.5], 1 mM
NaCl, 5 mM MgCl2, 1 mM DTT). Fractions were analyzed by SDS-PAGE
and native PAGE for the presence of assembled Mm-cpn. The fractions
containing Mm-cpn were pooled and diluted 4-fold into column buffer A
and applied to a MonoQ 16/10 anion exchange column (GE). Elution was
achieved as described above, and the relevant fractions were identified by
running on 12% SDS-PAGE. These fractions were pooled and precipi-
tated with 70% ammonium sulfate, resuspended in column C buffer (30
Group II Chaperonin Can Function in a Group I Organism
October 2016 Volume 198 Number 19 jb.asm.org 2693Journal of Bacteriology
 o
n
 January 23, 2017 by University of Birm
ingham
http://jb.asm.org/
D
ow
nloaded from
 
mM Tris-HCl [pH 7.5], 100 mM KCl, 5 mM MgCl2, 1 mM DTT), and
applied to an S300 HiPrep 26/60 column (GE) preequilibrated with buffer
C. After analysis by SDS-PAGE and native PAGE, relevant fractions were
pooled and concentrated up to 10 mg/ml using Amicon Ultra-15 centri-
fuge devices. The pure preparations were supplemented with 10% glycerol
and stored at70°C.
Enzymatic activity assays. For the citrate synthase (CS) aggregation
assay, 200 nM subunits (100 nM dimer) porcine heart citrate synthase
(Sigma) was mixed in 1 ml of CS assay buffer (30 mM morpholinepro-
panesulfonic acid [MOPS]-KOH [pH 7.5], 300 mM KCl, 5 mM MgCl2)
with Mm-cpn proteins in a 1:1 molar ratio (i.e., 200 nM Mm-cpn hexa-
decameric complex). The reaction mixture was incubated in a preheated
water bath at 50°C. The extent of aggregation was followed by measuring
the light scattering at 320 nm over a period of 30 min. ATP hydrolysis
activity was determined by measuring liberated Pi in a malachite green
assay as described previously (35, 36). Briefly, ATP and Mm-cpn protein
were mixed (final concentrations, 1 mM and 5M complex, respectively)
in an ATPase assay buffer (30 mM Tris-HCl [pH 7.5], 300 mM KCl, 5 mM
MgCl2, and 1 mM DTT) and incubated at 37°C for 15 min. The reaction
was stopped by addition of 10 mM EDTA followed by colorimetric detec-
tion (640 nm). Rhodanese reactivation was done as described previously
(34). Proteinase K sensitivity was measured by incubating purified Mm-
cpn proteins and its mutants at a concentration of 0.8125M complex in
50 l of assay buffer (30 mM MOPS-KOH [pH 7.5], 300 mM KCl, 5 mM
MgCl2, 5 mM MgCl2, and 1 mM DTT). The reaction was started by addi-
tion of ATP or ADP to a final concentration of 1 mM. When metal fluo-
ride complexes were to be generated, AlFx [5 mM Al(NO3)3 and 30 mM
KF] was added to the mixture before the addition of ATP or ADP. Next, 1
g/ml proteinase K was added, and the samples were incubated for 15 min
at 30°C. PMSF (5 mM; 100% [vol/vol] in ethanol) was added to inhibit
protease activity, and the samples were immediately mixed with SDS load-
ing dye to be analyzed by 12% SDS-PAGE.
Western blotting. Following the separation of proteins by SDS-
PAGE, electrotransfer to polyvinylidene difluoride (PVDF) membranes
(Immobilon-P), and overnight blocking with nonfat dried milk, mem-
branes were probed with a 1:1,000 dilution of a rabbit polyclonal antise-
rum raised against the thermosome of Thermoplasma acidophilum, gen-
erously provided by Gundula Bosch. Bound antibody was detected using
the ECL Plus kit (Amersham).
RESULTS
Group II chaperonin from the archaeon Methanococcus mari-
paludis can sustain growth of E. coli cells depleted for GroES
and GroEL. E. coli strain TAB21 is a derivative of strain BL21 in
which the chromosomal groE promoter has been replaced by the
pBAD promoter (37). Repression of the pBAD promoter function
in TAB21 cells leads to an inability to grow on glucose-containing
medium, as GroES and GroEL are essential for survival and are
depleted once this promoter has been repressed, largely by dilu-
tion as cells divide. Complementation by another chaperonin will
occur only if this chaperonin can functionally replace GroEL and
GroES. We used this strain to test the ability of Mm-cpn to act as
a functional chaperonin in E. coli. TAB21 was transformed with a
pET21-derived plasmid expressing the Mm-cpn gene under the
control of an IPTG-inducible T7 promoter, and expression and
assembly of the Mm-cpn protein was confirmed when the pro-
moter was induced. To test the ability of Mm-cpn to complement
for loss of GroES and GroEL function, TAB21 cells expressing
Mm-cpn were grown in the presence of arabinose overnight and
then transferred to media containing glucose. Dilutions of these
cultures were spotted onto plates containing glucose or arabinose,
and these were then incubated at 26°C, 30°C, and 37°C. Cells
expressing Mm-cpn showed growth and formed small colonies on
plates containing glucose after approximately 5 days of incubation
at 26°C and 30°C (Fig. 1A), showing that Mm-cpn can at least
partially overcome the lack of growth caused by depletion of
GroES and GroEL. No growth was observed at 37°C unless arabi-
nose replaced glucose in the medium (Fig. 1B).
Selection of Mm-cpn variants showing enhanced ability to
replace GroES and GroEL in E. coli. Because Mm-cpn showed
partial complementation TAB21 at reduced temperatures, we
speculated that it should be possible to isolate variants with im-
proved function in E. coli. To do this, we combined rounds of
random mutagenesis with visual screening by growth under
groESL-repressed conditions. pET-Mm-cpn was mutagenized by
growth in the XL-1 mutator strain of E. coli, and TAB21 cells were
transformed with a pool of plasmids prepared from this strain,
with selection on glucose plates at 26°C, 30°C, and 37°C. Under
these conditions, we observed some faster-growing colonies at
26°C and 30°C. After restreaking and verification of the pheno-
type, plasmids were isolated from these putative mutants, and the
cpn genes within them were sequenced. Two single point muta-
tions, one at position 216 from lysine to glutamate and the second
at position 223 from methionine to isoleucine, were isolated using
this procedure. To ensure that no other mutations could be caus-
ing the improved-growth phenotype, we individually reintro-
duced both M223I and K216E mutations into the cpn gene in
pET-Mm-cpn and analyzed the ability of these mutants to support
growth following dilution and spotting on glucose plates as de-
scribed in Materials and Methods. Growth for both mutants was
clearly faster than for wild-type (WT) Mm-cpn organisms under
GroES/GroEL-limiting conditions (Fig. 2). We also examined the
growth properties in liquid medium of the strains expressing the
mutated Mm-Cpn proteins (see Fig. S1 posted at http://epapers
.bham.ac.uk/2176/). Cells ceased to grow after 2 h of GroES/
GroEL depletion unless they expressed Mm-cpn proteins. Cells
expressing Mm-cpn showed slow and limited growth beyond this
point, while those expressing Mm-cpn-K216E or Mm-cpn-M223I
grew rapidly and to a high optical density, consistent with the
phenotype seen on solid medium. To ensure that the phenotype
FIG 1 M. maripaludis chaperonin Mm-cpn can partially rescue growth of E.
coli TAB21 under GroE-limiting conditions. TAB21 cells containing plasmids
pET21 and pET21-Mm-cpn grown on 0.2% glucose (groE repression) and 1
mM IPTG (Mm-cpn induction) at 26°C (A) and on arabinose (groE induc-
tion) at 37°C (B).
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was not due to improved expression or assembly, we compared
the proteins on SDS-PAGE and native gels. All the Mm-cpn pro-
teins were expressed at high levels when induced (see Fig. S2A
posted at http://epapers.bham.ac.uk/2176/) and assembled
equally well into 900-kDa complexes (see Fig. S2B posted at
the same URL).
K216 and M223 are both in the apical domain of the Mm-cpn
complex and attain different positions in its open and closed con-
formations (see Fig. S3 posted at http://epapers.bham.ac.uk/217
6/). The K216 residue faces toward the inner surface of the cavity
and contributes to the hydrophilic nature of the cavity, as de-
scribed previously (38). The M223 residue lies in a loop beneath
helix 11 near the helical protrusion and is on the outer surface of
the chaperonin in a surface representation of the closed Mm-cpn
complex. When compared across 20 different archaeal species,
K216 and M223 were found to be 100% and 95% conserved, re-
spectively.
Mm-cpn containing mutations at K216 can replace GroEL
function. Although the results mentioned above showed that
Mm-cpn had some ability to replace GroES and GroEL, which was
further enhanced by the two mutations, they do not demonstrate
complete functionality, as some residual group I activity may be
present even in the depleted strains. We therefore investigated the
ability of the different Mm-cpn variants to support growth in the
complete absence of GroEL. This was done using strain AI90,
which has a kanamycin resistance cassette replacing groEL.
Growth of this strain is maintained by ptrc-regulated groEL on an
expression plasmid that also encodes a sacB gene (32, 33). When a
plasmid expressing Mm-cpn is introduced into this strain, cells
will undergo plasmid shuffling, and those in which the original
groEL-bearing plasmid has been displaced can be selected for by
growth on sucrose (see Fig. S4 posted at http://epapers.bham.ac
.uk/2176/); loss of the plasmid can be confirmed by chloramphen-
icol sensitivity of the colonies. Growth will occur only if the Mm-
cpn variant can completely replace GroEL.
Cells were transformed with plasmids expressing Mm-cpn,
Mm-cpn-M223I, and Mm-cpn-K216E and grown at 26°C, 30°C,
and 37°C in the presence of sucrose. As a positive control, cells
transformed with plasmid bearing wild-type groEL were also
grown under similar conditions. Apart from the positive control,
growth was observed only for cells expressing the mutant Mm-
cpn-K216E. These cells showed distinct visible colonies after 3
days at 26°C and 30°C in numbers comparable to those observed
for cells expressing GroEL (Table 1). Cells expressing Mm-cpn-
K216E also formed visible colonies at 37°C after 5 days. Loss of the
plasmid-encoded groEL from these transformants was confirmed
by chloramphenicol sensitivity and by colony PCR (see Fig. S5
posted at http://epapers.bham.ac.uk/2176/). The transformants
expressing Mm-cpn-K216E showed a complete absence of GroEL
protein (Fig. 3, upper panel, lanes 2 and 3) and expression of
Mm-cpn protein (Fig. 3, lower panel, lanes 2 and 3). Thus, the
Mm-cpn-K216E mutant can support growth of cells completely
lacking GroEL, but wild-type Mm-cpn and the Mm-cpn-M223I
mutant cannot.
To further assess the significance of the K216 and M223 sites
for improved GroEL complementation of Mm-cpn, we intro-
duced a range of other amino acids at these positions. Those mu-
tant proteins that expressed and assembled correctly were tested
for complementation in TAB21. Cells expressing almost all K216
substitutions had an improved phenotype at 30°C compared to
cells expressing Mm-cpn (Table 2; see also Fig. S6 posted at http:
//epapers.bham.ac.uk/2176/). Some substitutions (K216C, D, G,
Q, S, and V) were better than others (K216A, F, L, P, T, and Y) and
resulted in a K216E-like phenotype; the only mutant that led to
poor growth was Mm-cpn-K216R. Every tested substitution at
M223 uniformly displayed an M223I-like improved phenotype
suggesting a broader range of functional flexibility at this residue
than the residue K216 (Table 3). To validate the various pheno-
types of TAB21 cells expressing different Mm-cpn-K216 substitu-
tions, a selection of K216 mutants (K216A, D, L, Q, R, and S) were
FIG 2 Random mutagenesis of Mm-cpn yielded mutants Mm-cpn-M223I
and Mm-cpn-K216E with improved phenotype in E. coli under GroEL- and
GroES-depleting conditions. TAB21 cells containing plasmids pET21, pET21-
Mm-cpn, pET21-Mm-cpn-M223I, and pET21-Mm-cpn-K216E grown on
0.2% glucose and 1 mM IPTG at 30°C for 5 days.
TABLE 1 Analysis of Mm-cpn functionality in groEL strain AI90
incubated in LB containing sucrose and IPTG
Temp (°C)
No. of coloniesa for cells expressing:
GroEL Mm-cpn WT Mm-cpn M223I Mm-cpn K216E
26    
30    
37    
a The results are indicative of the average number of colonies obtained for each sample
from three independent experiments. The number of cells transformed, amounts of
DNA used, and dilutions plated were uniformly maintained to be of equal number.
Symbols:, no colonies;, between 10 and 50 colonies;, between 50 and 100
colonies;, between 100 and 200 colonies.
FIG 3 AI90 cells expressing Mm-cpn-K216E contain no GroEL protein.
Western blots of soluble protein extracts from cultures using anti-GroEL and
antithermosome antibodies. Lane 1, DH5	; lane 2, AI90/ptrc-Mm-cpn-K216E
(26°C); lane 3, AI90/ptrc-Mm-cpn-K216E (30°C); lane 4, Mm-cpn purified
protein (low concentration).
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tested for their ability to sustain growth in complete absence of
GroEL using the AI90 complementation system. AI90 cells ex-
pressing Mm-cpn-K216D, K216Q and K216S gave a number of
colonies similar to the number of colonies of cells expressing Mm-
cpn-K216E (Table 3). Cells expressing Mm-cpn-K216A and
K216L showed poor growth, and expression of Mm-cpn-K216R
did not support growth of the cells in complete absence of GroEL,
consistent with the results from TAB21 analysis.
Complementation byMm-cpn requires ATPase activity. We
wished to determine whether the complementing Mm-cpn mu-
tants are functioning as true ATP-dependent chaperones when
they complement loss of GroEL and GroES or whether comple-
mentation is due to some other indirect effect, such as providing a
larger hydrophobic surface on which nascent unfolded proteins
could bind, thus reducing the need for GroEL. To test this, the
mutation D386A that blocks the ATPase activity of the chaperonin
was introduced. The D386A mutant can bind to ATP but is unable
to hydrolyze it (15, 48), hence stopping the chaperonin from un-
dergoing a folding cycle by locking Mm-cpn in its ATP-bound
open conformation. If Mm-cpn-K216E and Mm-cpn-M223I are
functioning by simply binding to the clients while in an open
conformation, the additional D386A mutation should not affect
the phenotype of the mutants. If, on the other hand, the mutants
are still acting as chaperonins requiring a full ATPase cycle, the
additional D386A mutation should prevent Mm-cpn from
supporting growth of the cells.
The D386A mutation was introduced into the cpn gene in
pET-Mm-cpn, pET-Mm-cpn-K216E, and pET-Mm-cpn-M223I.
Strains containing these plasmids were first checked to confirm
that the Mm-cpn derivatives were correctly expressed and as-
sembled in TAB21 (see Fig. S7 posted at http://epapers.bham.ac
.uk/2176/) and then checked for complementation on glucose
plates. As shown in Fig. 4, introduction of D386A into Mm-cpn
significantly reduces its ability to complement for loss of GroES
and GroEL, as do the Mm-cpn-K216E-D386A and Mm-cpn-
M223I-D386A double mutants. Thus, loss of ATPase activity se-
verely affects the complementing ability of the wild-type and mu-
tant Mm-cpn proteins. This supports the hypothesis that the
Mm-cpn-K216E and Mm-cpn-M223I mutants act as genuine
chaperonins and must complete an ATP-dependent chaperonin
cycle to function in E. coli.
TABLE 2 Summary of the functional growth analysis of TAB21 cells
expressing Mm-cpn-M223 and Mm-cpn-K216 mutants at 30°Ca
Mutation in Mm-cpn Complementation in TAB21 (30°C)
Lysine mutations
K216A 
K216C 
K216D 
K216F 
K216G 
K216L 
K216P 
K216Q 
K216R 
K216S 
K216T 
K216V 
K216Y 
Methionine mutations
M223I 
M223F 
M223G 
M223E 
M223L 
M223R 
M223S 
M223V 
M223W 
M223Y 
a The results are indicative of the average number of colonies obtained for each sample
from three independent experiments. The number of cells transformed, amounts of
DNA used, and dilutions plated were uniformly maintained to be of equal number.
Symbols:, no colonies;, between 10 and 50 colonies;, between 50 and 100
colonies;, between 100 and 200 colonies.
TABLE 3 Summary of the functional growth analysis of AI90 cells expressing Mm-cpn K216 mutants at 30°C and 37°Ca
Addition(s) to LB agar Temp (°C)
No. of colonies for cells expressing:
Mm-cpn
K216E
Mm-cpn
K216A
Mm-cpn
K216D
Mm-cpn
K216L
Mm-cpn
K216Q
Mm-cpn
K216R
Mm-cpn
K216S
Sucrose 30       
Sucrose and IPTG 30       
Sucrose 37       
Sucrose and IPTG 37       
a The results are indicative of the average number of colonies obtained for each sample from three independent experiments. The number of cells transformed, amounts of DNA
used, and dilutions plated were uniformly maintained to be of equal number. Symbols:, no colonies;, between 10 and 50 colonies;, between 50 and 100 colonies;,
between 100 and 200 colonies.
FIG 4 Growth of D386A mutants at 30°C under GroEL-depleting conditions.
TAB21 cells expressing Mm-cpn-D386A mutants as indicated under pET21
vector grown on 0.2% glucose and 1 mM IPTG at 30°C for 5 days.
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Biochemical characterization of Mm-cpn-M223I and Mm-
cpn-K216E. We analyzed the biochemical properties of the mu-
tants to see whether a reason for their improved function in E. coli
could be determined. We envisaged that the mutations could
change the biochemical behavior of chaperonin oligomers to en-
able them to cycle more rapidly or to bind or fold client proteins
more effectively. To test this, we purified the wild-type Mm-cpn
and the Mm-cpn-K216E and Mm-cpn-M223I proteins (see Fig.
S8 posted at http://epapers.bham.ac.uk/2176/). The melting tem-
peratures as deduced from circular dichroism melting curves were
similar to that of the wild-type protein (results not shown), show-
ing that there are no significant differences in thermal stability
between the proteins. We therefore tested for their ability to bind
and fold clients, examined their rates of ATP hydrolysis, and com-
pared their nucleotide-dependent conformational cycle to that of
wild-type Mm-cpn.
We first tested the ability of Mm-cpn mutants to bind to por-
cine heart citrate synthase as a nonnative model substrate in an
aggregation prevention assay as described previously (34). Incu-
bation of citrate synthase at 50°C resulted in a rapid increase in
OD320 of the solution over a period of 30 min. However, the pres-
ence of equimolar concentrations (Mm-cpn complex to enzyme
subunit) of Mm-cpn, Mm-cpn-K216E, or Mm-cpn-M223I was
sufficient to suppress the aggregation (Fig. 5A). Thus, the Mm-
cpn mutant complexes can bind substrate protein efficiently and
behave like WT Mm-cpn in this particular assay, but there is no
clear difference in the functions of the mutant and wild-type pro-
teins.
We assessed ATPase activities for all three proteins (Fig. 5B)
and observed that the mutants can effectively hydrolyze ATP. The
mutant Mm-cpn-K216E exhibited a rate of ATP hydrolysis fairly
similar to that of the wild-type, whereas a reproducible drop in
activity was observed for the mutant Mm-cpn-M223I.
Client refolding was assessed using rhodanese, which is widely
used as a model client to test the in vitro refolding ability of both
GroEL (39, 40) and Mm-cpn (34). Rhodanese was denatured us-
ing 6 M guanidinium chloride (GuHCl) and refolded by incuba-
tion with an equimolar amount of Mm-cpn wild-type or mutant
proteins in the presence of ATP. As shown in Fig. 5C, approxi-
mately 60% to 70% recovery of native rhodanese was observed for
Mm-cpn-M223I and K216E. There was not a significant differ-
ence in the values obtained for the mutants compared to those
obtained for the wild type as observed here or reported previously.
However, Mm-cpn-M223I consistently showed a slightly lower
refolding activity than did Mm-cpn-K216E, which in turn showed
activity that was almost identical to that of Mm-cpn.
Chaperonins exhibit different conformations at different
stages of the folding cycle. To determine the asymmetric confor-
mations of chaperonin complexes in the presence of different nu-
cleotides, a simple assay based on susceptibility of digestion by a
protease has been described (41, 42) and extensively used for both
group I and group II chaperonins. If the point mutations Mm-
cpn-K216E and Mm-cpn-M223I led to conformational changes
of the complex or an alteration of time spent in the different con-
formations, the pattern of proteolytic digestion would be different
from that of the wild type. To test this possibility, both mutants
were subjected to a proteinase K sensitivity assay. Mm-cpn-K216E
was partially protected against proteolytic cleavage in the presence
of ATP and to a greater extent in the presence of ATP-AlFx, similar
to the observations for wild-type protein (Fig. 6A). The mutant
FIG 5 (A) Binding ability of Mm-cpn mutants as assessed by citrate synthase
aggregation assay. Citrate synthase (CS) in the absence or presence of the
various Mm-cpn proteins as indicated was incubated at 50°C, and the increase
in attenuance was measured at 320 nm for 30 min as an endpoint for the assay.
The Mm-cpn proteins and CS were used in equimolar concentrations (ratio of
Mm-cpn complex to enzyme subunit). The data represent averages from three
independent experiments. (B) ATP hydrolysis activity of Mm-cpn mutants.
The Mm-cpn proteins were incubated in appropriate buffers at 37°C, and the
ATPase activity was initiated by adding 1 mM ATP (final concentration) and
continued for 15 min. The release of phosphate was assayed by the malachite
green-molybdate method, and the absorbance at 640 nm was recorded. The
data observed for Mm-cpn mutants are plotted as percentages of the data
obtained for the wild type. (C) Rhodanese-refolding ability of Mm-cpn
mutants. GuHCl-denatured rhodanese was incubated in the absence or
presence of various proteins as indicated in an appropriate buffer contain-
ing 1 mM ATP at room temperature for 30 min. The data observed for
Mm-cpn proteins are plotted as a percentage of the activity of native rho-
danese.
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Mm-cpn-M223I, on the other hand, was rather weakly protected
against protease digestion (Fig. 6B), suggesting that this protein
spends more time in open conformation rather than closed, con-
sistent with its lower ATPase activity. When the nonhydrolyzable
ATP analogue, AMP-PNP, was used, effective proteinase K pro-
tection was reduced, consistent with ATP hydrolysis being impor-
tant to attain the closed conformation as reported previously (15,
48) (Fig. 6A).
DISCUSSION
We have demonstrated that a group II homo-oligomeric chaper-
onin from a mesophilic archaeon can partly replace E. coli GroEL
and GroES function in vivo and that mutations that show im-
proved function can be isolated and are sufficient in the case of
mutations at K216 to allow deletion of the groEL gene. The bio-
chemical endpoint assays reported here do not show any signifi-
cant differences between the mutants and the wild-type Mm-cpn
protein that might explain the improved ability of the mutants, in
particular the K216 mutants, to complement for loss of GroEL
function; more-detailed analysis may yet reveal subtle differences
that are important in vivo. We also considered the possibility that
better complementation by Mm-cpn would be obtained by coex-
pressing the prefoldins PfdA and PfdB from M. maripaludis, as
these proteins are known to improve group II chaperonin func-
tion (43). Successful coexpression was achieved, but no improve-
ment in complementation was observed under our experimental
conditions (data not shown). We speculate that improved func-
tion is due to improved folding of a specific subset of clients, which
is hence not captured by the assays that we used here. We note that
K216 faces the inside of the chaperonin cage (see Fig. S3 posted at
http://epapers.bham.ac.uk/2176/), so it is possible that the effect
that we see with mutants at this position is in part due to a loss of
positive charge on the cage surface. The wall of the GroEL cavity is
enriched with negatively charged residues (net surface charge
is42) in contrast to the comparatively neutral distribution of the
Mm-cpn cavity (19), and the negatively charged clusters of the
GroEL cage wall have been implicated in facilitating the folding of
bacterial clients (44, 45). Changing three negatively charged resi-
dues facing the inner cavity of GroEL to positive results in strong
reduction of cell growth (44). This suggests the likelihood of neg-
atively charged residues having a role in efficient folding by
GroEL, potentially by providing local repulsion to acidic proteins,
predominantly found in E. coli (46). Although the interpretation
of these results has been challenged (47), it would be interesting to
change the more positively charged residues facing the inner cav-
ity of Mm-cpn to negative, ideally corresponding to the ones
tested by Tang et al. (44) and to analyze the effects on E. coli
growth in the absence of GroEL.
We also propose that the improved complementation of the
mutant Mm-cpn-M223I despite its relatively lower ATPase activ-
ity could be due to better client binding owing to slower folding
kinetics. Because it spends more time in an open conformation, a
larger number of client proteins could bind and hence stabilize
transiently. However, folding of at least some clients (even with
slow ATP turnover) would depend on Mm-cpn-M223I, as block-
ing the ATPase activity by the D386A mutation leads to cessation
of growth. The results thus suggest that both active folding of
clients and slow aggregation kinetics of the misfolded proteins
could jointly contribute to the improved GroEL-complementing
ability of Mm-cpn-M223I.
Our findings provide an insight into the relationship between
the group I and group II chaperonins, showing that they are not as
diverse in their functional properties as has been previously sug-
gested, and additionally provide a novel experimental platform
that can be used to rapidly analyze the in vivo properties of a group
II chaperonin.
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